A detailed history of Hexagon Capital Partners LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 1,212 shares of MYGN stock, worth $16,543. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,212
Previous 1,143 6.04%
Holding current value
$16,543
Previous $27,000 22.22%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$23.97 - $28.6 $1,653 - $1,973
69 Added 6.04%
1,212 $33,000
Q2 2024

Jul 12, 2024

BUY
$17.98 - $25.47 $8,828 - $12,505
491 Added 75.31%
1,143 $27,000
Q1 2024

Apr 18, 2024

BUY
$17.59 - $23.59 $4,872 - $6,534
277 Added 73.87%
652 $13,000
Q4 2023

Feb 05, 2024

BUY
$13.91 - $21.32 $5,216 - $7,995
375 New
375 $7,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.